Ultralife Corporation
ULBI
$4.13
-$0.15-3.51%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 291.00K | 258.00K | 2.97M | 2.89M | 2.84M |
| Total Depreciation and Amortization | 1.18M | 994.00K | 1.02M | 968.00K | 966.00K |
| Total Amortization of Deferred Charges | 47.00K | 12.00K | 16.00K | 16.00K | 16.00K |
| Total Other Non-Cash Items | 249.00K | 92.00K | 927.00K | 824.00K | 168.00K |
| Change in Net Operating Assets | 1.28M | 3.39M | 4.00M | -4.78M | -1.56M |
| Cash from Operations | 3.05M | 4.75M | 8.93M | -81.00K | 2.43M |
| Capital Expenditure | -606.00K | -594.00K | -360.00K | -372.00K | -1.01M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -48.02M | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -48.63M | -594.00K | -360.00K | -372.00K | -1.01M |
| Total Debt Issued | 55.00M | -- | -- | -- | 1.00M |
| Total Debt Repaid | -8.04M | -4.03M | -13.18M | -500.00K | -1.50M |
| Issuance of Common Stock | 39.00K | 24.00K | 1.25M | 685.00K | 207.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -8.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.32M | -68.00K | -- | -- | -- |
| Cash from Financing | 45.68M | -4.08M | -11.93M | 185.00K | -301.00K |
| Foreign Exchange rate Adjustments | -18.00K | 9.00K | -46.00K | 89.00K | -149.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 80.00K | 84.00K | -3.41M | -179.00K | 977.00K |